Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Palonosetron (0.25mg) Injection
Therapeutic Category
Anticancer, Oncology
Dosage Form
Injection
Packaging Type
Vial
Packaging
0.25mg
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Palsone Injection containing Palonosetron is used for the prevention of nausea and vomiting associated with chemotherapy, surgery, and other medical treatments. It helps provide effective antiemetic support and improves patient comfort.
Palonosetron works as a selective serotonin 5-HT3 receptor antagonist that blocks signals responsible for triggering nausea and vomiting.
The injection is widely prescribed in oncology, surgical, and hospital care settings for supportive treatment management, leading to consistent institutional demand.
With increasing demand for advanced supportive care therapies in hospitals and oncology practice, this product offers strong business potential for retailers and distributors. Its long-lasting antiemetic action, broad clinical relevance, and steady market demand make it a reliable product for growth in the supportive care segment.
Some patients may experience headache, constipation, dizziness, fatigue, or injection site discomfort. Rarely, allergic reactions, cardiac rhythm disturbances, or severe hypersensitivity reactions may occur and require immediate medical attention.
Palsone Injection is indicated for the prevention of chemotherapy-induced nausea and vomiting (CINV), postoperative nausea and vomiting (PONV), and radiotherapy-associated nausea and vomiting. It helps improve patient comfort and treatment tolerance.
This injection should be administered strictly under medical supervision by qualified healthcare professionals. Use cautiously in patients with cardiac disorders or electrolyte imbalance. Follow the prescribed dosage and administration schedule carefully.
Store below 25°C, protected from direct sunlight and moisture. Keep the vial in its original packaging and out of reach of children.
Composition : Ceftriaxone (250mg) + Sulbactam (125mg)
Composition : Ceftriaxone (250mg) + Tazobactum (31.25mg)
Composition : Ceftriaxone (500mg)
Composition : Ceftriaxone (500mg) + Sulbactam (250mg)
Composition : Cefuroxime (1500mg)
Composition : Cefuroxime (1.5gm)
Composition : Cefuroxime (1500mg) + Sulbactam (750mg)
Composition : Clarithromycin (500mg) Injection
Composition : Clindamycin (300mg) Injection
Composition : Clindamycin (600mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Palonosetron 0.25mg Injection has strong demand in the hospital, oncology, surgery, and anti-emetic segment, making it a valuable product for distributors, wholesalers, and pharma franchise partners focusing on injectable supportive care portfolios.
Distributors and agencies can benefit from consistent hospital usage for nausea and vomiting control under medical supervision. Palonosetron 0.25mg is a 5-HT3 receptor antagonist used as a powerful antiemetic Commonly used for chemotherapy-induced nausea and vomiting (CINV), post-operative nausea and vomiting (PONV), and radiotherapy-related nausea Has a long duration of action compared to older antiemetics Widely used in oncology wards, operation theatres, and ICU settings Frequently prescribed by oncologists, surgeons, and anesthetists This strengthens a comprehensive hospital anti-emetic and supportive care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Palonosetron Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from steady institutional demand, oncology and surgical usage, repeat hospital procurement, and strong prescription reliability, along with dependable supply chain support and attractive margins in the injectable segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from professional marketing support, quality pharmaceutical products, and a dependable supply chain for long-term hospital business growth.